Interferon Lambda genetic polymorphisms and viral infection: The tip of the Iceberg?

DNA and Cell Biology

Volumn 33, Issue 2, 2014, Pages 60-63

  Russell, Clark D ^a   Griffiths, Samantha J ^a   Haas, Jürgen ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENETIC VARIATION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKINS; MICE; SPECIES SPECIFICITY; VIRUS DISEASES;

EID: 84893832436     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2261     Document Type: Article

References (22)

1. Aparicio, E., Parera, M., Franco, S., Perez-Alvarez, N., Tural, C., Clotet, B., and Martinez, M.A. (2010). IL28B SNP rs8099917 is strongly associated with pegylated interferon-A and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients. PLoS One 5, e13771.
2. Chapman, S.J., and Hill, A.V. (2012). Human genetic susceptibility to infectious disease. Nat Rev Genet 13, 175-188.
3. Contoli, M., Message, S.D., Laza-Stanca, V., Edwards, M.R., Wark, P.A., Bartlett, N.W., Kebadze, T., Mallia, P., Stanciu, L.A., Parker, H.L., Slater, L., Lewis-Antes, A., Kon, O.M., Holgate, S.T., Davies, D.E., Kotenko, S.V., Papi, A., and Johnston, S.L. (2006). Role of deficient type III interferonlambda production in asthma exacerbations. Nat Med 12, 1023-1026. (Pubitemid 44353382)
4. Ge, D., Fellay, J., Thompson, A.J., Simon, J.S., Shianna, K.V., Urban, T.J., Heinzen, E.L., Qiu, P., Bertelsen, A.H., Muir, A.J., Sulkowski, M., McHutchison, J.G., and Goldstein, D.B. (2009). Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399-401.
5. Griffiths, S.J., Koegl, M., Boutell, C., Zenner, H.L., Crump, C.M., Pica, F., Gonzalez, O., Friedel, C.C., Barry, G., Martin, K., Craigon, M.H., Chen, R., Kaza, L.N., Fossum, E., Fazakerley, J.K., Efstathiou, S., Volpi, A., Zimmer, R., Ghazal, P., and Haas, J. (2013). A systematic analysis of host factors reveals a Med23-interferon-l regulatory axis against herpes simplex virus type 1 replication. PLoS Pathog 9, e1003514.
6. Lampertico, P., Viganò , M., Cheroni, C., Facchetti, F., Invernizzi, F., Valveri, V., Soffredini, R., Abrignani, S., De Francesco, R., and Colombo, M. (2013). IL28B polymorphisms predict interferon- related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B. Hepatology 57, 890-896.
7. Langhans, B., Kupfer, B., Braunschweiger, I., Arndt, S., Schulte, W., Nischalke, H.D., Nattermann, J., Oldenburg, J., Sauerbruch, T., and Spengler, U. (2011). Interferon-lambda serum levels in hepatitis C. J Hepatol 54, 859-865.
8. Liao, Y., Li, Y., Cai, B., Chen, J., and Wang, L. (2013). Lack of association between interleukin 28B polymorphisms and spontaneous viral clearance in hepatitis B virus patients. Clin Infect Dis 57, 620-622.
9. Mordstein, M., Kochs, G., Dumoutier, L., Renauld, J.C., Paludan, S.R., Klucher, K., and Staeheli, P. (2008). Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4, e1000151.
10. Mordstein, M., Neugebauer, E., Ditt, V., Jessen, B., Rieger, T., Falcone, V., Sorgeloos, F., Ehl, S., Mayer, D., Kochs, G., Schwemmle, M., Günther, S., Drosten, C., Michiels, T., and Staeheli, P. (2010). Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol 84, 5670-5677.
11. Park, H., Serti, E., Eke, O., Muchmore, B., Prokunina-Olsson, L., Capone, S., Folgori, A., and Rehermann B. (2012). IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection. Hepatology 56, 2060-2070.
12. Pica, F., Volpi, A., Gaziano, R., and Garaci, E. (2010). Interferonlambda in immunocompetent individuals with a history of recurrent herpes labialis. Antivir Ther 15, 737-743.
13. Pott, J., Mahlako iv, T., Mordstein, M., Duerr, C.U., Michiels, T., Stockinger, S., Staeheli, P., and Hornef, M.W. (2011). IFNlambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A 108, 7944-7949.
14. Prokunina-Olsson, L., Muchmore, B., Tang, W., Pfeiffer, R.M., Park, H., Dickensheets, H., Hergott, D., Porter-Gill, P., Mumy, A., Kohaar, I., Chen, S., Brand, N., Tarway, M., Liu, L., Sheikh, F., Astemborski, J., Bonkovsky, H.L., Edlin, B.R., Howell, C.D., Morgan, T.R., Thomas, D.L., Rehermann, B., Donnelly, R.P., and OBrien, T.R. (2013). A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45, 164-171.
15. Sato, M., Kato, N., Tateishi, R., Muroyama, R., Kowatari, N., Li, W., Goto, K., Otsuka, M., Shiina, S., Yoshida, H., Omata, M., and Koike, K. (2013). IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J Gastroenterol [Epub ahead of print]; DOI: 10.1007/s00535-013-0826-x.
16. Seto, W.K., Wong, D.K., Kopaniszen, M., Proitsi, P., Sham, P.C., Hung, I.F., Fung, J., Lai, C.L., and Yuen, M.F. (2013). HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B. Clin Infect Dis 56, 1695-1703.
17. Sommereyns, C., Paul, S., Staeheli, P., and Michiels, T. (2008). IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4, e1000017.
18. Sonneveld, M.J., Wong, V.W., Woltman, A.M., Wong, G.L., Cakaloglu, Y., Zeuzem, S., Buster, E.H., Uitterlinden, A.G., Hansen, B.E., Chan, H.L., and Janssen, H.L. (2012). Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B. Gastroenterology 142, 513-520.
19. Srensen, T.I., Nielsen, G.G., Andersen, P.K., and Teasdale, T.W. (1988). Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318, 727-732. (Pubitemid 18090256)
20. Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate,M.L., Bassendine, M., Spengler, U., Dore, G.J., Powell, E., Riordan, S., Sheridan, D., Smedile, A., Fragomeli, V., Müller, T., Bahlo, M., Stewart, G.J., Booth, D.R., and George, J. (2009). IL28B is associated with response to chronic hepatitis C interferon- alpha and ribavirin therapy. Nat Genet 41, 1100-1104.
21. Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., Ito, Y., Mita, E., Tanaka, E., Mochida, S., Murawaki, Y., Honda, M., Sakai, A., Hiasa, Y., Nishiguchi, S., Koike, A., Sakaida, I., Imamura, M., Ito, K., Yano, K., Masaki, N., Sugauchi, F., Izumi, N., Tokunaga, K., and Mizokami, M. (2009). Genome-wide association of IL28B with response to pegylated interferon-Alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41, 1105-1109.
22. Thomas, D.L., Thio, C.L., Martin, M.P., Qi, Y., Ge, D., OHuigin, C., Kidd, J., Kidd, K., Khakoo, S.I., Alexander, G., Goedert, J.J., Kirk, G.D., Donfield, S.M., Rosen, H.R., Tobler, L.H., Busch, M.P., McHutchison, J.G., Goldstein, D.B., and Carrington, M. (2009). Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798-801.